![Rapid Hepatitis C Treatment Initiation in Young People Who Inject Drugs: Final Results from the HCV-Seek, Test & Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial Rapid Hepatitis C Treatment Initiation in Young People Who Inject Drugs: Final Results from the HCV-Seek, Test & Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial](https://www.natap.org/2021/images/111521/111521-11/1115211.gif)
Rapid Hepatitis C Treatment Initiation in Young People Who Inject Drugs: Final Results from the HCV-Seek, Test & Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial
![Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial | The BMJ Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1022/F1.medium.jpg)
Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial | The BMJ
![Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice - ScienceDirect Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X16301793-gr1.jpg)
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice - ScienceDirect
![Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial - The Lancet Gastroenterology & Hepatology Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/ec90add7-52c8-4c47-9cac-1c980dc8fa06/gr1_lrg.jpg)
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial - The Lancet Gastroenterology & Hepatology
![A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/5f70e2ed-642c-49e3-9230-5eba1fc35e56/gr1.gif)
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial - The Lancet Gastroenterology & Hepatology
![Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or](https://www.thelancet.com/cms/attachment/2110455934/2083206639/gr1.gif)
Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or
![Breakthroughs in hepatitis C research: from discovery to cure | Nature Reviews Gastroenterology & Hepatology Breakthroughs in hepatitis C research: from discovery to cure | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41575-022-00608-8/MediaObjects/41575_2022_608_Fig1_HTML.png)
Breakthroughs in hepatitis C research: from discovery to cure | Nature Reviews Gastroenterology & Hepatology
![Viruses | Free Full-Text | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance Viruses | Free Full-Text | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance](https://pub.mdpi-res.com/viruses/viruses-08-00176/article_deploy/html/images/viruses-08-00176-g002.png?1467188516)
Viruses | Free Full-Text | Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
![Sofosbuvir/Velpatasvir for Patients With Chronic Genotype 3 HCV Infection With Compensated Cirrhosis: an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials Sofosbuvir/Velpatasvir for Patients With Chronic Genotype 3 HCV Infection With Compensated Cirrhosis: an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials](https://www.natap.org/2018/images%20/111418/111418-6/1114181.gif)
Sofosbuvir/Velpatasvir for Patients With Chronic Genotype 3 HCV Infection With Compensated Cirrhosis: an Integrated Analysis of Phase 2 and Phase 3 Clinical Trials
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://www.hcv-trials.com/studies/solar-1/Diapositive1.jpg)